Biotech Values

[ghmm]

I expected given their management of known AE's the SVR rate would be even better especially since it seems they cut the drop out number substantially. But I didn't sit down and do the math to see if the number is above what would have been expected.

EDIT: OK your right (of course) I went back over the phase 2 results and the improvement over placebo taking into account the reduced drop outs looks improved especially considering this is a much larger study.